Home Novartis Reports Novel Tissue-Specific E3 Ligase (TRIM58) Ligands for Targeted PROTAC Development

Novartis Reports Novel Tissue-Specific E3 Ligase (TRIM58) Ligands for Targeted PROTAC Development

Dec 24, 2023 06:30 CST Updated 06:30
Novartis

Drug Development and Manufacturing